[go: up one dir, main page]

FI891227A7 - Katekolijohdannaiset ja niitä sisältävät farmaseuttiset valmisteet - Google Patents

Katekolijohdannaiset ja niitä sisältävät farmaseuttiset valmisteet Download PDF

Info

Publication number
FI891227A7
FI891227A7 FI891227A FI891227A FI891227A7 FI 891227 A7 FI891227 A7 FI 891227A7 FI 891227 A FI891227 A FI 891227A FI 891227 A FI891227 A FI 891227A FI 891227 A7 FI891227 A7 FI 891227A7
Authority
FI
Finland
Prior art keywords
pharmaceutical preparations
preparations containing
catechol derivatives
catechol
derivatives
Prior art date
Application number
FI891227A
Other languages
English (en)
Swedish (sv)
Other versions
FI891227A0 (fi
FI891227L (fi
Inventor
Nobuyuki Fukazawa
Kengo Otsuka
Shizuo Shimada
Yukio Miyama
Fumiaki Ikeda
Tatsuo Kaiho
Original Assignee
Mitsui Toatsu Chemicals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6351588A external-priority patent/JPH0696520B2/ja
Priority claimed from JP63201866A external-priority patent/JPH0720929B2/ja
Application filed by Mitsui Toatsu Chemicals Incorporated filed Critical Mitsui Toatsu Chemicals Incorporated
Publication of FI891227A0 publication Critical patent/FI891227A0/fi
Publication of FI891227A7 publication Critical patent/FI891227A7/fi
Publication of FI891227L publication Critical patent/FI891227L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI891227A 1988-03-18 1989-03-15 Katekolderivat och farmaceutiska preparat som innehaoller dessa. FI891227L (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6351588A JPH0696520B2 (ja) 1988-03-18 1988-03-18 カテコールアミン誘導体を含有してなる中枢性神経退行性疾患の進行防止および治療剤
JP6351688 1988-03-18
JP20186588 1988-08-15
JP63201866A JPH0720929B2 (ja) 1988-08-15 1988-08-15 ジヒドロカフェイン酸アミド化合物およびそれを有効成分として含有する治療剤

Publications (3)

Publication Number Publication Date
FI891227A0 FI891227A0 (fi) 1989-03-15
FI891227A7 true FI891227A7 (fi) 1989-09-19
FI891227L FI891227L (fi) 1989-09-19

Family

ID=27464327

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891227A FI891227L (fi) 1988-03-18 1989-03-15 Katekolderivat och farmaceutiska preparat som innehaoller dessa.

Country Status (8)

Country Link
EP (1) EP0333522B1 (fi)
KR (1) KR910008665B1 (fi)
AU (1) AU602628B2 (fi)
DE (1) DE68917499T2 (fi)
DK (1) DK130389A (fi)
FI (1) FI891227L (fi)
NO (1) NO891191L (fi)
NZ (1) NZ228329A (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT94121A (pt) * 1989-05-23 1991-02-08 Sankyo Co Processo para a preparacao de derivados fenol para promover o factor de crescimento do nervo humano
JPH0660141B2 (ja) * 1989-09-12 1994-08-10 三井東圧化学株式会社 ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
FR2669029B1 (fr) * 1990-11-14 1994-09-02 Adir Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE148098T1 (de) * 1991-02-21 1997-02-15 Sankyo Co Benzolderivate zum fördern der produktion des nervenwachstumsfaktors
US5480907A (en) * 1991-05-16 1996-01-02 Takeda Chemical Industries, Ltd. Aromatic amide compounds and their production and use
CA2103367A1 (en) * 1991-05-20 1992-11-21 Akihide Koda Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
CZ20022720A3 (cs) * 2000-02-11 2002-11-13 Vertex Pharmaceuticals Incorporated Deriváty piperazinu a piperidinu pro pouľití při léčení a prevenci poąkozených neuronů
ES2328938T3 (es) * 2005-02-28 2009-11-19 Tseti, Ioulia Medicamento para el alzheimer.
KR100957465B1 (ko) * 2006-08-10 2010-05-14 (주)아모레퍼시픽 히드록시신남산 유도체 화합물과 그 제조방법 및 이를함유하는 화장료 조성물
MX2011011082A (es) * 2009-04-20 2011-11-04 Abbott Lab Derivados de amida y amidina novedosos y usos de los mismos.
US8507493B2 (en) 2009-04-20 2013-08-13 Abbvie Inc. Amide and amidine derivatives and uses thereof
DE102009031342A1 (de) 2009-07-01 2011-01-05 Daimler Ag Verwendung von Schmierölen mit mikrogekapselten Schmierstoffadditiven, Verwendung derselben in Schmierölen für Kraftfahrzeuge mit Verbrennungsmotor und Verbrennungsmotor mit mikrogekapselte Schmierstoffadditive enthaltenden Schmieröl
FR2964866B1 (fr) * 2010-09-22 2013-03-29 Oreal Utilisation comme antipelliculaire de derives ortho-diphenol, nouveaux composes et composition cosmetique les comprenant
WO2013034457A1 (en) * 2011-09-06 2013-03-14 Novaliq Gmbh Lipophilic dopamine derivatives and their use
KR101327817B1 (ko) 2012-03-22 2013-11-08 (주)에이씨티 미백 효과를 나타내는 아마이드 유도체의 제조방법 및 상기 아마이드 유도체를 함유하는 화장료 조성물
MX386251B (es) * 2013-03-15 2025-03-18 Techfields Pharma Co Ltd Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
WO2016090355A2 (en) * 2014-12-05 2016-06-09 Massachusetts Institute Of Technology Catechol-rich polymers from n-substituted maleimides
JP2021522196A (ja) * 2018-04-20 2021-08-30 ザ ジェネラル ホスピタル コーポレイション 血液脳関門を越えて送達するためのアセチル化プロドラッグ
CN114478296B (zh) * 2022-02-14 2024-07-19 河南旭瑞新材料科技有限公司 一种二氢燕麦生物碱的制备方法
KR20250106753A (ko) 2024-01-03 2025-07-11 건국대학교 글로컬산학협력단 카테콜 유도체가 결합된 담즙산을 포함하는 대사성 질환 예방 및 치료용 약학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181738A (en) * 1976-11-30 1980-01-01 Cornell Research Foundation, Inc. Catecholamine derivatives, a process for their preparation and pharmaceutical compositions thereof
US4529604A (en) * 1977-03-28 1985-07-16 Smithkline Beckman Corporation N,N-Di-(n-Propyl)dopamine derivatives
US4424205A (en) * 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
FR2562889B1 (fr) * 1984-04-17 1988-10-28 Glaxo Group Ltd Composes de phenethanolamine. procede pour leur preparation et compositions pharmaceutiques les comprenant
US4579866A (en) * 1984-05-29 1986-04-01 Usv Pharmaceutical Corp. Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents
GB2178031B (en) * 1985-06-10 1989-07-26 Procter & Gamble Phenylacetic acid amides having anti-inflammatory and analgesic activity
FI874163A7 (fi) * 1986-09-26 1988-03-27 Mitsui Toatsu Chemicals Incorporated Katekolijohdannaiset sekä niitä sisältävät keskushermoston taantumasairauksia ehkäisevät ja parantavat valmisteet.

Also Published As

Publication number Publication date
NZ228329A (en) 1991-12-23
DE68917499D1 (de) 1994-09-22
DK130389A (da) 1989-09-19
AU3144389A (en) 1989-09-21
FI891227A0 (fi) 1989-03-15
FI891227L (fi) 1989-09-19
DK130389D0 (da) 1989-03-17
KR890014098A (ko) 1989-10-21
DE68917499T2 (de) 1995-02-09
NO891191L (no) 1989-09-19
EP0333522B1 (en) 1994-08-17
AU602628B2 (en) 1990-10-18
NO891191D0 (no) 1989-03-17
EP0333522A3 (en) 1991-04-17
KR910008665B1 (ko) 1991-10-19
EP0333522A2 (en) 1989-09-20

Similar Documents

Publication Publication Date Title
FI891227A7 (fi) Katekolijohdannaiset ja niitä sisältävät farmaseuttiset valmisteet
FI942181A7 (fi) Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FI935071A7 (fi) Uudet perhydroisoindolit, niiden valmistus ja niitä sisältävät farmase uttiset valmisteet
FI910286A7 (fi) Ihmisen insuliinin analogit ja niitä sisältävät valmisteet
FI894611A7 (fi) Rakeisia farmaseuttisia valmisteita
DE3483713D1 (de) Hydroxypyridon-derivate und sie enthaltende pharmazeutische zubereitungen.
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
FI981654L (fi) Rasvaliukoisia aineita sisältäviä stabiileja valmisteita
EE03110B1 (et) Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
FI864559A7 (fi) Uudet insuliinijohdannaiset ja näitä johdannaisia sisältävät farmaseu ttiset valmisteet.
FI900313A7 (fi) Uudet bentsopyraanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FI931336A7 (fi) Polyhydroksimetyleenijohdannaisia sisältäviä lääkkeitä, menetelmä niiden valmistamiseksi ja käyttämiseksi
DK272486A (da) Tienopyridoner og farmaceutiske praeparater indeholdende dem
DK166355C (da) Adenosin-derivater samt farmaceutiske praeparater indeholdende saadanne derivater
DK257089A (da) Cycloalkylsubstituerede glutaramid-derivater og farmaceutiske praeparater indeholdende disse
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
FI932388A7 (fi) 8-eeni-19,11b-siltasteroidit, niiden valmistus ja niitä sisältävät far maseuttiset valmisteet
DK272386A (da) Quinoloner og farmaceutiske praeparater indeholdende dem
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK269289A (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
FI892963A7 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI895603A7 (fi) Peneemi-johdannaiset ja menetelmiä niiden valmistamiseksi
DK488688D0 (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: MITSUI TOATSU CHEMICALS, INCORPORATED